NGR Peptide 1 – 1 mg

Overview

NGR Peptide 1 (Asn-Gly-Arg) is a specialized peptide that features a disulfide bridge connecting cysteine residues 1 and 5, known for its significant antimicrobial properties. This peptide includes the KLA sequence, which enhances its effectiveness against various tumor cells. With potent cytotoxicity, NGR Peptide 1 binds specifically to CD13 present on tumor cells, facilitating targeted therapeutic applications. You can count on NGR Peptide 1 to show a dose-dependent antiproliferation effect on tumor cells, inducing cell cycle arrest at the G2/M phases and promoting apoptosis efficiently.

Key Features

• Contains NGR motif for targeted delivery
• Induces dose-dependent cytotoxicity against tumor cells
• Promotes cell cycle arrest at G2/M phases
• Enhances antimicrobial activity
• Ideal for research and diagnostic applications

Specifications

FAQ

What is NGR Peptide 1 used for?

NGR Peptide 1 is primarily utilized in research focused on tumor biology due to its binding affinity to CD13, allowing it to effectively target and induce cytotoxic effects on tumor cells.

How does NGR Peptide 1 affect tumor cells?

This peptide demonstrates significant antiproliferative activity, leading to cell cycle arrest and apoptosis in tumor cells, making it a promising candidate for cancer therapy research.

Is NGR Peptide 1 suitable for diagnostic applications?

Yes, due to its unique properties and mechanisms, NGR Peptide 1 can be applied in various diagnostic assays and research settings.

If you’re exploring potent agents for your research or diagnostic needs, consider adding NGR Peptide 1 to your inventory. Shop now and enhance your project with this remarkable peptide.

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.